(1-苯磺酰基-1H-吡咯-3-基)(4-硝基苯基)甲酮 | 200344-65-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: (1-苯磺酰基-1H-吡咯-3-基)(4-硝基苯基)甲酮
• 英文名称: (1-benzenesulfonyl-1H-pyrrol-3-yl)(4-nitrophenyl)methanone
• 英文别名: [1-(Benzenesulfonyl)pyrrol-3-yl]-(4-nitrophenyl)methanone
• CAS: 200344-65-6
• 化学式: C₁₇H₁₂N₂O₅S
• 分子量: 356.359
• InChiKey: CKGIXEMGJPYSMI-UHFFFAOYSA-N

物化性质

• 沸点：
  593.5±56.0 °C(Predicted)
• 密度：
  1.40±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  25
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  110
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  (1-苯磺酰基-1H-吡咯-3-基)(4-硝基苯基)甲酮 在 sodium hypophosphite 作用下， 以 四氢呋喃 为溶剂， 生成 (1-苯磺酰基-1H-吡咯-3-基)(4-氨基苯基)甲酮
  参考文献：
  名称：

  Substituted Pyrrol-1-ylacetic Acids That Combine Aldose Reductase Enzyme Inhibitory Activity and Ability To Prevent the Nonenzymatic Irreversible Modification of Proteins from Monosaccharides

  摘要：

  Starting from the known inhibitory activity of (3-benzoylpyrrol-1-yl)acetic acid (1) and (2-benzoylpyrrol-1-yl)acetic acid (II), a series of 3-aroyl and 2,4-bis-aroyl derivatives (54-75) were synthesized and tested for inhibition of aldose reductase, an enzyme involved in the appearance of diabetic complications. It was found that a number of the tested compounds exhibited considerable activity in the micromolar range. Important structural features for the potent compounds is the presence of substituents with relatively low Hammett sigma values and/ or moieties which increase their overall aromatic area. The most active derivative was the [2,4-bis(4-methoxybenzoyl)pyrrol-1-yl] acetic acid (75), with potency favorably compared to known ARIs such as tolrestat, epalrestat, zopolrestat, and fidarestat. Four selected derivatives were also evaluated for their ability to interfere with the oxidative modification of serum albumin in an in vitro experimental glycation model of diabetes mellitus. All of them showed considerable activity, comparable to the known inhibitor trolox. Our results, taken together, indicate that compound 75 combines favorably two biological activities directly connected to a number of pathological conditions related to the chronic diabetes mellitus.

  DOI：

  10.1021/jm0209477
• 作为产物：
  描述：

  1-(苯基磺酰基)吡咯 、 4-硝基苯甲酰氯 在 三氯化铝 作用下， 以 二氯甲烷 为溶剂， 反应 1.5h， 生成 (1-苯磺酰基-1H-吡咯-3-基)(4-硝基苯基)甲酮
  参考文献：
  名称：

  1-苯磺酰基-1 H-吡咯的Friedel-crafts酰化制备3-芳酰基吡咯的研究

  摘要：

  在这项工作中，我们研究了氯化铝催化的1-苯磺酰基-1 H-吡咯与一系列11种芳酰氯的反应。形成的产物不是分离的，而是水解成目标3-芳基吡咯的总产率，通常高于50％。但是，在富含π电子的1-苯基-1 H-吡咯-3-羰基氯和1-甲基-1 H-吲哚-3-羰基氯的情况下，发生了显着的C-2取代，导致分离出相应的1-苯磺酰基-2-芳酰基吡咯作为主要或唯一产品。从1-三异丙基硅烷基-1 H-吡咯开始合成所需的C-3异构体。

  DOI：

  10.1002/jhet.5570350619

文献信息

• Pyrrole Butyric Acid Derivatives as Inhibitors of Steroid 5.ALPHA.-Reductase.
  作者：Masaya KATO、Keiko KOMODA、Akira NAMERA、Yusuke SAKAI、Satoshi OKADA、Akira YAMADA、Kouichi YOKOYAMA、Emiko MIGITA、Yasushi MINOBE、Tadato TANI

  DOI：10.1248/cpb.45.1767

  日期：——

  A series of pyrrole butyric acid derivatives was synthesized and evaluated for inhibitory activity on human and rat steroid 5α-reductase in vitro and ex vivo. 3-Benzoyl-4-alkylpyrrole-1-butyric acids and 1-methyl-2-alkyl-3-benzoylpyrrole-5-butyric acid derivatives were effective inhibitors. Structure activity relationships were evaluated among the 37 compounds synthesized. Compound 37 (HQL-1069) shows potent inhibitory activities against both rat and human 5α-reductase.

  合成了一系列吡咯丁酸衍生物，并评估了其对人类和大鼠类固醇5α-还原酶的抑制活性（体外和体外）。3-苯甲酰-4-烷基吡咯-1-丁酸和1-甲基-2-烷基-3-苯甲基吡咯-5-丁酸衍生物为有效抑制剂。在合成的37个化合物中评估了结构-活性关系。化合物37（HQL-1069）对大鼠和人类5α-还原酶均表现出强效的抑制活性。